Top Banner
Innovating the Capital Appropriation Process Jose Rivera, P.E. Barry Holtz, Ph.D Brent Pilgrim
32

Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Jul 27, 2018

Download

Documents

habao
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Innovating the Capital Appropriation Process

Jose Rivera, P.E. Barry Holtz, Ph.D Brent Pilgrim

Page 2: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Innovating the Capital Appropriation Process

• Jose Rivera, P.E. – HC Beck, Ltd.

• Project Executive

• Barry Holtz, Ph.D – Holtz Biopharma Consulting

• Principal Consultant

• Brent Pilgrim, Beck Technology

• Director of Services

Members of the Klyo Collaborative

Page 3: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Presentation Outline• Innovation in Process/Facility Design & Planning

• Business Drivers for Process/Facility Design & Planning

• Regulatory Changes/Drive Toward “Design Space”

• Relevant Technology Improvements

• Innovative Solution – DESTINI Profiler

• DESTINI Profiler Introduction & Video

• Benefits of this Solution

Page 4: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

“Virtualizing the Planning of Manufacturing Processes within Facility Design, using Parametric Tools”

Page 5: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

“Valley of Financial Pain”(EOPII & Phase III Plan: 18 Mos)

Phase III Trials & Launch

Clinical Timelines & Facility Requirements“Valley of Death”(Discovery to Phase I: 5 Yrs)

Phase II Trials(Phase IIA Phase IIB: 4 Yrs)

ManufacturingTrials

*Early Facility Design and Process Integration Decreases Time to Market!

OpportunityManufacturing

TrialsIntegrated EPCV

(18months – 2 years)

Traditional Design/Bid/Build(Approximately 3-4 Yrs)

CAPEXGate #1

CAPEXGate #2

CAPEXGate #3

CAPEXGate #4

CAPEXGate #1

CAPEXGate #2

CAPEXGate #3

Page 8: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Process/Architecture/Engineering Challenges

• Planning & Design Process is Slow & Imprecise

• Prolonged Decisions Making

• Costly Initial Work & Costlier Rework

• Delayed Product Delivery

Page 9: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Regulatory Paradigm & “Quality by Design”

Quality Risk Management

Quality by Design (Pharmaceutical Development)

Existing GMP’s

Development & Manufacture

Quality Systems

Regulatory

Quality System

ICH – Q10

ICH – Q9

ICH – Q11

ICH – Q8

Page 10: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

QbD Should Initiate a Design Continuum

Assess

QbD

QTPP ValidationRisk

AnalysisProcess

Development

Facility Design/Information Management/Automation

Rework loops occur at each step, but the continuum starts at the benchtop!

Page 11: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Relevant Technology Improvements

• Building Information Modeling (BIM)

• Intelligent Objects

• Virtual Analysis

• Process Modeling

• Rapid Prototyping

Page 12: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Simulation & Modeling Systems

Current Software for Process Modeling:

• Intelligen – SuperPro Designer

• INOSIM – Process Edition

• AspenTech – AspenOne

• BioPharm – Biosolve Process

No current simulation system offer parametric

process modeling and facility design simultaneously!

Page 13: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Simulation & Modeling Systems

DESTINI Profiler

• Planning stage conceptual modeling

• Equipment based space planning

• Real-time costing

• What-if scenario analysis testing

Page 14: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

“Virtualizing the Planning of Manufacturing Processes within Facility Design, using Parametric Tools”

Page 15: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

3D Cost Modeling with Process Integration

Block Diagram Process Flow Diagram

Page 16: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

3D Cost Modeling with Process Integration

Process Flow Diagram Equipment Specifier

Page 17: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

3D Cost Modeling with Process Integration

Equipment Specifier Equipment Placement

Page 18: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

3D Cost Modeling with Process Integration

Equipment Placement Convert to Model Object(Space or Program Requirement)

Intelligent object with:-Physical dimensions-Utility requirements-Room Finishes, etc.-Detailed Cost

Page 19: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

3D Cost Modeling with Process Integration

Convert Space Populate Room Card

Page 20: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

3D Cost Modeling with Process Integration

Layout Spaces in Model Convert to Functional Plan

Page 21: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

3D Cost Modeling with Process Integration

Floor Plan(Product, Material, Waste, & People Flow)

Convert to Baseline Building

Model

Page 22: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

3D Cost Modeling with Process IntegrationBegin Detailed Analysis & Scope Refinement

Page 23: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

3D Cost Modeling with Process Integration

• Process Flow Diagram

• Equipment List

• Floor Plan

• Design Criteria

• Detailed Construction Cost

• Schedule

Reports & Other Deliverables

Page 24: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

• Design Costs (A/E, Process)

• Automation Costs

• Capital Costs (Construction Cost)

• Commissioning/Startup (2%-4%)

• Validation (4%)

• Owner Management Cost (5%)

• Land/City/State/Fed Costs

• Permits

Owner Current Concept & Expectations

Solutions/Evaluation/Feasibility Study

Capital Appropriation Package

Preliminary Engineering

Basic Engineering

AED Project Approval/Bid

Design/Build

Startup / Commissioning

IQ/OQ Protocols

Process Validation

3D Cost Modeling with Process IntegrationCapital Appropriation Package

Page 25: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Video

Page 26: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

“Valley of Financial Pain”(EOPII & Phase III Plan: 18 Mos)

Phase III Trials & Launch

Technology Implementation Timeline“Valley of Death”(Discovery to Phase I: 5 Yrs)

Phase II Trials(Phase IIA Phase IIB: 4 Yrs)

ManufacturingTrials

OpportunityManufacturing

TrialsIntegrated EPCV

(18months – 2 years)

Traditional Design/Bid/Build(Approximately 3-4 Yrs)

Early EvaluationBench/Pilot

Mid-Stage Eval Process Optimization

Design & Budget for Design/Build

1 2 3

1 2 3

CAPEXGate #1

CAPEXGate #2

CAPEXGate #3

CAPEXGate #4

CAPEXGate #1

CAPEXGate #2

CAPEXGate #3

Page 27: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

TOGW -38%

(Vandenbrande 2006)Ta

ke-o

ff g

ross

we

igh

t ra

tio

Excess Propellant Fraction

Feasible Range

Inspiration: Boeing’s RCD Process

The Future of This Innovation – “Optioneering”

Page 28: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Billions of

Potential

Solutions

The Future of This InnovationToday’s Design Practice

• Allows for 5-9 Design Options

• Focuses on 3-4 Major Issues

• Takes 6-8 Months

• Spends Money

• Wastes Time

Page 29: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

The Future of This Innovation

…Is the Current Design Effort Good Enough?

If there are Thousands of Potential Solutions in the Overall Design Space…

Page 30: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Billions of

Potential

Solutions

The Future of This Innovation

Tomorrow:

• Thousands of options

• Multiple parameters

• Two weeks

• SAVES money

• SAVES time

• ADD value

Page 31: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Optioneering at 50,000 ftThe Future of This Innovation

+

KEY

Baseline

Lowest Cost

Lowest Carbon Footprint

3 Buildings, 5 Stories

3 Buildings, 6 Stories

3 Buildings, 7 Stories

3 Buildings, 8 Stories

4 Buildings, 5 Stories

4 Buildings, 6 Stories

4 Buildings, 7 Stories

4 Buildings, 8 Stories

Infeasible Solution

Page 32: Innovating the Capital Appropriation Process - The Beck …€¦ · Innovating the Capital Appropriation Process ... • AspenTech –AspenOne • BioPharm –Biosolve Process No

Questions

• Jose Rivera, P.E. – HC Beck, Ltd.

• Project Executive

• Barry Holtz, Ph.D – Holtz Biopharma Consulting

• Principal Consultant

• Brent Pilgrim, Beck Technology

• Director of Services

Members of the Klyo Collaborative